PHONE
+44-7482-878921
+44-7482-878921
2376-0249
Clinical-Medical Image - International Journal of Clinical & Medical Images (2024) Volume 11, Issue 4
Author(s): Luigi Civardi*
Department of Neurology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan
Received: 29 March, 2024, Manuscript No. ijcmi-24-140910; Editor assigned: 01 April, 2024, Pre QC No. P-140910; Reviewed: 15 April, 2024, QC No. Q-140910; Revised: 20 April, 2024, Manuscript No. R-140910; Published: 29 April, 2024, DOI:10.4172/2376-0249.1000955
Citation: Civardi L. (2024) Advances in Imaging for Rare Neurological Disorders. Int J Clin Med Imaging 11: 955.
Copyright: © 2024 Civardi L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Advancements in imaging techniques have significantly improved the diagnosis and management of rare neurological disorders. These cutting-edge technologies, including high-resolution MRI and advanced PET scans, enable clinicians to detect subtle abnormalities and earlystage pathologies that were previously challenging to identify. This progress has not only enhanced diagnostic accuracy but also facilitated better treatment planning and monitoring of disease progression. By providing detailed insights into the structural and functional aspects of the brain, these imaging advancements are transforming patient care and opening new avenues for research in the field of neurology [1].
Moreover, the integration of artificial intelligence and machine learning algorithms in imaging analysis has further refined the precision and speed of diagnosing these rare conditions. AI-driven tools can analyze vast amounts of imaging data rapidly, identifying patterns and anomalies that may be overlooked by the human eye. This synergy between technology and clinical expertise is leading to earlier interventions, personalized treatment approaches, and improved outcomes for patients with rare neurological disorders. As these technologies continue to evolve, they hold the promise of unlocking deeper understanding and more effective therapies, ultimately enhancing the quality of life for affected individuals [2].
Neurology research; Imaging techniques; Early diagnosis
None.
[1] Robert C, Schachter J, Long GV, Arance A and Grob JJ, et al. (2015). Pembrolizumab vs. ipilimumab in advanced melanoma. N Engl J Med 372 (26): 2521-2532.
Google Scholar, Crossref, Indexed at
[2] Ramos-Casals M. and Sisó-Almirall A. (2024). Immune-related adverse events of immune checkpoint inhibitors. Ann Intern Med 177(2): ITC17-ITC32.
Awards Nomination
